FDA Inspection 1266565 — Vitalant

Vitalant — FEI 1672593

The FDA completed an inspection of Vitalant on March 26, 2025 in Midland, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 26, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Midland, TX (United States)